Khan, Kamran
Mistry, Hema
Matharu, Manjit
Norman, Chloe
Petrou, Stavros
Stewart, Kimberley
Underwood, Martin
Achana, Felix
Article History
Received: 13 May 2022
Accepted: 13 October 2022
First Online: 26 October 2022
Declarations
:
: Written informed consent was obtained from study participants prior to participation in the test and validation sample data collection exercises. For the validation study, ethics approval was provided by the Northwest—Greater Manchester East Research Ethics Committee (REC REF: 16/NW/0890).
: NA
: MU reports personal fees from National Institute for Health Research, grants from National Institute for Health Research, grants from Versus Arthritis, other from multiple professional conferences, grants from Stryker Ltd, grants from SERCO Ltd, other from Confederation for Advanced Research Training in Africa (CARTA) and personal fees from Clinvivo Ltd, outside the submitted work. MU reports he has been a Chief Investigator on multiple research grants from Australian National Health and Medical Research Council. FG reports grants from NIHR during the conduct of the study. MM reports grants, personal fees and honorarium for serving on advisory board from Allergan, honorarium for serving on advisory board from Novartis, personal fees and honorarium for serving on advisory board from Eli Lilly, personal fees and honorarium for serving on advisory board from TEVA, grants from Abbott, grants from Medtronic, grants from electroCore, personal fees and honorarium for serving on advisory board from Salvia. In addition, MM has a patent WO2018051103A1 issued.